Posted by AGORACOM-JC
at 4:03 PM on Wednesday, September 16th, 2020
Sometimes, you just have to let the numbers speak for themselves. With 165,000 patients, Empower Clinics (CBDT:CSE) (EPWCF:OTCQB) has a database that almost every medical cannabis and CBD company would kill for … but then these numbers came in for the first two quarters:
Revenues $USD 1.7M vs $745,000 = 130% Gain
Patient Visits 12,400 vs 5,500 = 125% Gain
CBDT has now delivered growth in 4 successive financial reports (Q4, FY 2019, Q1 and Q2), so it is safe to say that superstar CEO Steve McAuley can officially claim victory on the turnaround he inherited in 2019.
But he is far from done.
CBDT also just announced the potential acquisition of an 8,000 sq ft lab in Dallas (they do everything big over there) that can process 2,000 COVID-19 tests per 8 hour shift. At an average price of ~ $USD 90 per test, the clinic could represent $USD 180,000 in revenue PER SHIFT. However, until this acquisition closes, we’re not going to focus on it too much – but that could happen as early as next week.
Moreover, CBDT has to actually fill that capacity, which McAuley says he is working on right now with some enterprise sized discussions taking place as we write. Can he pull it off? First consider what he has already accomplished after inheriting a catastrophe of a company. Secondly, McAuley, is Six Sigma certified under the quality initiative of legendary GE (General Electric) Chairman Jack Welch. We’ve never seen a Six Sigma certified CEO in the Canadian small cap markets. Never …. which explains how McAuley has been able to guide Empower Clinics through the most disruptive retail environment in recent history and turn it into significant growth … and gives us optimism about this acquisition.
Posted by AGORACOM-JC
at 9:11 AM on Wednesday, September 16th, 2020
Received second Purchase Order (P.O.) for COVID-19 screening solutions with Lighthouse Pictures Inc., a Film and Television production company based in Vancouver, British Columbia
The service is scheduled to commence on September 16, 2020.
Datametrex anticipates that it will have little or no upfront costs associated with importing and selling these test kits
Toronto, Ontario–(September 16, 2020) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC: DTMXF) (the “Company” or “Datametrex”) is pleased to announce it has received second Purchase Order (P.O.) for COVID-19 screening solutions with Lighthouse Pictures Inc., a Film and Television production company based in Vancouver, British Columbia. The service is scheduled to commence on September 16, 2020. Datametrex anticipates that it will have little or no upfront costs associated with importing and selling these test kits.
Lighthouse Pictures is a company that specializes in producing genre and mid-to small-budget film and television projects. Industry leaders Shawn Williamson and Jamie Goehring helm Lighthouse Pictures. With over 65 productions in the past ten years, Lighthouse Pictures productions continue to be recognized. Year after year, Lighthouse projects have received industry praise with Canadian Screen Awards nominations, and numerous Leo Awards.
Vancouver is the third-largest production centre in North America, worth CDN $3.2 Billion during 2018/19, according to Creative BC. British Columbia is home to several world-class Film and TV studios, including Bridge Studios, Mammoth Studios, Vancouver Film Studios, North Shore Studios, Ironwood Studios, Canadian Motion Picture Park, and The Crossing Studios.
They all produce, on average, approximately 65+ movies and 55+ TV series annually, as well as hundreds of other filming days for commercials, TV pilots and other features. This industry generates over 42,000 direct and indirect jobs in Film and TV production, with more than 80 percent located in Metro Vancouver. British Columbia is world-renowned as a versatile and dependable hub for motion picture production.
Entire film and TV production in Canada represent $8.92 Billion in production volume, and full-time equivalent jobs represent 179,000 workers. In March 2020, the industry stopped in Vancouver, and the surrounding areas had 46 productions filming which does not include the TV commercial market. Each of the shows would have a minimum of a 100-person film crew. (source: https://www.creativebc.com/about-us/research-and-reports/index)
This demonstrates that Canada can be an advocate for the Film industry, as we have testing and labs already set up throughout. Additionally, Canada has far fewer instances of coronavirus with 139,146 cases, compared with more than 6,545,948 in the US, according to data compiled by Johns Hopkins University.
“With our pre-screening and screening tools, this industry can resume and provide us with the much-needed entertainment that this newly indoor, online-based culture requires”, said Marshall Gunter CEO of the Company.
These tools were developed as a direct response to customer needs and the ever-changing physical distancing recommendations, safety guidelines, and workplace flexibility initiatives being observed across North America and around the globe.
About Datametrex
Datametrex AI Limited is a technology-focused with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.
For further information, please contact: Marshall Gunter – CEO Phone: (514) 295-2300 Email: [email protected]
Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not historical may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.
Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the time such forward-looking information is made. Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.
Posted by AGORACOM-JC
at 7:09 AM on Wednesday, September 16th, 2020
Announces the signing of an agreement with the University of Houston Athletics to implement Loop’s contactless, artificial intelligence marketing solutions
Will provide personalized promotions and targeted engagement, as well as, Loop’s leading contact tracing solutions for the purposes of supporting resumption plans that provide a safe environment for fans and guests attending Houston football games at TDECU Stadium
Loop’s e-commerce solutions will be integrated within the platform to provide fans with an ability to purchase event tickets, concessions, merchandise products, and parking services without having to use physical cash
VANCOUVER, BC, Sept. 16, 2020 – Loop Insights Inc. (MTRX: TSXV) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive automated marketing, contact tracing, and contactless solutions to the brick and mortar space, is pleased to announce the signing of an agreement with the University of Houston Athletics (“UH”) to implement Loop’s contactless, artificial intelligence marketing solutions to provide personalized promotions and targeted engagement, as well as, Loop’s leading contact tracing solutions for the purposes of supporting resumption plans that provide a safe environment for fans and guests attending Houston football games at TDECU Stadium.
The University of Houston is a public research university in Houston, Texas, and the main institution of the University of Houston System. Founded in 1927, UH is the third-largest university in Texas, with over 47,000 students.
LOOP SOLUTION TO PROVIDE HOUSTON ATHLETICS WITH ABILITY TO ACHIEVE CASHLESS AND CONTACTLESS GOALS
Given the health risks related to COVID-19 and the uncertainty about the duration of its impact on society, UH Athletics will be working with Loop in the development and implementation of a contactless and cashless solution for fans and guests attending events at TDECU Stadium. Loop’s services will help Houston Athletics deliver on this goal by first implementing its contact tracing solution, which will provide Houston football fans and guests safe and secure access when attending events.
Secondly, Loop’s e-commerce solutions will be integrated within the platform to provide fans with an ability to purchase event tickets, concessions, merchandise products, and parking services without having to use physical cash.
Finally, with users now using the platform to conduct their purchases and access events, Loop’s artificial intelligence marketing services will provide unmatched personalized promotions and engagement opportunities, creating a more interactive fan experience at Houston athletic events. Loop’s services and technologies will offer a more robust game day experience for all Houston football fans.
Loop Insights CEO Rob Anson stated, “Our first priority is reopening and keeping campus doors open through our proven and scalable contact tracing platform. Secondly, we want to help UH maintain and increase its revenues. We expect to generate meaningful revenue from monthly fees associated to active users on the Loop platform as well through participation in a revenue share. With our integrated product stack, UH and all of the other 356 NCAA Div.1 colleges can gain immediate access to all of Loop’s products and services and benefit from increased profitability through streamlined operational efficiencies. We intend to deliver a future proof campus experience, so the next wave of Covid-19 does not close their doors for good. Loop is the complete solution.”
University of Houston‘s Deputy Athletic Director David Tagliarino stated, “A main goal for us is to administer enhanced safety protocols and best practices, measures that instill confidence among our fans and guests during these challenging times due to Covid-19. Loop’s solution is appealing because it also provides fully automated and personalized fan experiences with large-scale user adoption and enhanced fan engagement opportunities. In addition to improving the way we interact with fans inside and outside the stadium, Loop’s contact tracing will greatly assist our efforts in returning fans to our venues in a safe and prudent manner.”
University of Houston Athletics sponsors 17 intercollegiate sports for nearly 400 student-athletes. The department’s mission is to develop its student-athletes into champions for life and focuses daily on the success and welfare of its student-athletes. A member of the American Athletic Conference, Houston has led its league in conference championships in each of the last five seasons. For more information on UH Athletics, visit UHCougars.com.
About Loop Insights
Loop Insights Inc. is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing, and contactless solutions to the brick and mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia.
Forward-Looking Statements/Information:
This news release contains certain statements which constitute forward-looking statements or information. Such forward-looking statements are subject to numerous risks and uncertainties, some of which are beyond Loop’s control, including the impact of general economic conditions, industry conditions, and competition from other industry participants, stock market volatility and the ability to access sufficient capital from internal and external sources. Although Loop believes that the expectations in its forward-looking statements are reasonable, they are based on factors and assumptions concerning future events which may prove to be inaccurate. Those factors and assumptions are based upon currently available information. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could influence actual results or events and cause actual results or events to differ materially from those stated, anticipated or implied in the forward-looking statements. As such, readers are cautioned not to place undue reliance on the forward-looking statements, as no assurance can be provided as to future results, levels of activity or achievements. The forward-looking statements contained in this news release are made as of the date of this news release and, except as required by applicable law, Loop does not undertake any obligation to publicly update or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise. The forward-looking statements contained in this document are expressly qualified by this cautionary statement. Trading in the securities of Loop should be considered highly speculative. There can be no assurance that Loop will be able to achieve all or any of its proposed objectives.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Posted by AGORACOM-JC
at 2:42 PM on Friday, September 11th, 2020
SPONSOR: Loop Insights Inc. (MTRX:TSX-V) is levelling the playing field between online retail giants and brick & mortar businesses. What if you could receive the same personalization and experience you get from online shopping, but in brick and mortar stores? Loop Insights is doing just that. Brick and mortar retail isn’t going anywhere, but it does need to adapt to offer better in-store customer experiences. Loop Insights solves a significant problem for traditional retailers – big and small – who are losing customers to e-commerce retail. Learn more.
IoT and Big Data: 6 Retail and Financial Services Trends to Watch Out For
IoT Will Revolutionize Point of Sale (POS) Payments
The POS industry is projected to be worth an estimated $109 billion by 2025, and IoT technology will play no small role in making this happen: while the best POS systems available today have a number of impressive features, POS technology will only evolve.
The rise of smart POS systems will result in the widespread adoption of biometric POS, the rise of mobile POS payments, digital product tracking that eliminates queues and makes remote payments easy, and much more
More importantly, IoT and big data enable the effective storage, processing, and transmission of data in a way that is more secure while providing advanced analytics that thoroughly monitors and notifies you of potential data breaches. This will make POS systems more secure and reliable further enhancing the retail industry.Bamidele Onibalusi – September 3, 2020
While the impact of the IoT industry in the past few years has been nothing short of impressive, the disruption this technology will bring to the financial services market will be just as impactful.
Below are six key trends that will drive the growth of IoT and big data in finance and retail.
1. IoT Will Make Risk Assessment Seamless and Easy
One area where IoT technology will be disruptive in the near future is that of risk assessment. Think about how risk assessment currently works in the financial services sector. It’s a very subjective process similar to the one that triggered the 2008 Great Recession. Now imagine a future that allows for smart risk assessment by using big data and IoT technologies.
First, IoT and big data will make it easy to acquire vast amounts of data that are used to determine a customers’ risk status. This data can then be smartly analyzed in a way that the risk profile of any company or individual becomes convenient and easy. The data can also be used to forecast future risks for individuals and organizations.
2. IoT Will Enhance and Automate Security in Financial Institutions
IoT technology will contribute to a more secure future, particularly in the retail and financial services industry.
Connected smart cameras and motion sensors are just two of the smart technologies financial institutions and retailers can deploy for better security. These technologies will not only automatically react to intrusions by thieves and unauthorized third parties (by shutting down certain systems, locking down the premises so that the intruder is unable to leave, and immediately notifying you and providing an abundance of information that you can act upon), but it will also act to protect against environmental hazards that can pose security threats or result in damage.
3. IoT Will Revolutionize Point of Sale (POS) Payments
The POS industry is projected to be worth an estimated $109 billion by 2025, and IoT technology will play no small role in making this happen: while the best POS systems available today have a number of impressive features, POS technology will only evolve. The rise of smart POS systems will result in the widespread adoption of biometric POS, the rise of mobile POS payments, digital product tracking that eliminates queues and makes remote payments easy, and much more.
More importantly, IoT and big data enable the effective storage, processing, and transmission of data in a way that is more secure while providing advanced analytics that thoroughly monitors and notifies you of potential data breaches. This will make POS systems more secure and reliable further enhancing the retail industry.
4. More Efficient Inventory Management
Retailers very well know the cost of an inefficient inventory management system. Data shows that U.S. retailers lose an estimated $45 billion annually due to not having the required inventory in stock and a whopping $224 billion due to having excess inventory.
IoT and big data will be able to fix inventory woes. Automated IoT inventory management systems that make real-time tracking of inventory easy at the point of sale will be in every retail store sooner rather than later. The inventory system automatically generates data to show currently in-stock items and effectively analyzes this data to predict future inventory requirements.
5. Smart Asset Movement and Monitoring
Asset monitoring is currently partially automated due to the use of computers and technology, but still involves a lot of manual process and checks. IoT and big data will change this.
First, IoT will automate the process of gathering data and real-time information that can be automatically analyzed to understand the current state of things and predict the future. IoT also makes effective use of sensors attached to assets to track them (paying attention to variables that include temperature, humidity, proximity, and movement) and then automatically generate useful data about these assets. This allows for enhanced real-time monitoring of the health and movement of assets.
6. Increasing Use of Wearable Tech for Financial Transactions
Smartwatches and wearable technology that automatically monitor human health and activity are increasingly prevalent. These devices provide essential information about the health of the wearer at all times. Now, think about something similar for payments: you walk into the bank and the bank’s IoT system connects to your wearable device which sends essential information about your activity to the bank. Not only does this eliminate a lot of time-wasting manual processes and improve customer satisfaction, but it also makes it easier to perform contactless transactions while at the same time ensuring optimal security.
The financial industry is already reaping the benefits of IoT and big data. As more businesses see the advantages of IoT, the adoption rate to improve outdated business practices will rapidly increase.
Posted by AGORACOM-JC
at 2:53 PM on Thursday, September 10th, 2020
SPONSOR: Loop Insights Inc. (MTRX:TSX-V) is levelling the playing field between online retail giants and brick & mortar businesses. What if you could receive the same personalization and experience you get from online shopping, but in brick and mortar stores? Loop Insights is doing just that. Brick and mortar retail isn’t going anywhere, but it does need to adapt to offer better in-store customer experiences. Loop Insights solves a significant problem for traditional retailers – big and small – who are losing customers to e-commerce retail. Learn more.
Why AI and IoT will play a big role in retail of tomorrow
While e-commerce’s growth has accelerated by “four to six years” according to a recent report published by Adobe indicated that on the ground retailers are now embracing digital-first approaches in order to acclimate to the new norms of social distancing and minimized contact
By enlisting artificial intelligence (AI) and Internet of Things (IoT) solutions, the retail sector is implementing new approaches to enhance customer experience, drive sales, and, most importantly, ensure the safety of employees and retailers in stores
The pandemic has left irreversible changes within the retail industry as consumer behavior during a time of limited and regulated movement evolved. A PYMNTS 2020 Remote Payments Study reported that mobile devices are the most popular device for online shopping, with up to 72% of consumers using their mobile devices to shop.
The explosion of online shopping saw an increase of 146% in online retail orders as of April 21, 2020 when compared to the same period last year. While e-commerce’s growth has accelerated by “four to six years” according to a recent report published by Adobe indicated that on the ground retailers are now embracing digital-first approaches in order to acclimate to the new norms of social distancing and minimized contact. By enlisting artificial intelligence (AI) and Internet of Things (IoT) solutions, the retail sector is implementing new approaches to enhance customer experience, drive sales, and, most importantly, ensure the safety of employees and retailers in stores.
AI
AI applications can accommodate multiple retail scenarios; AI in the retail market is set to hit US$19.9 billion by 2027, with leading brands already placing AI in storefronts.
Luxury department store Neiman Marcus makes it easier for customers to find items through visual search. The company’s Snap.find.shop. app is powered by AI, and it enables customers to seek items that match closely with photos they’ve taken.
At Macy’s, customers can seek the assistance of the company’s On Call app for a better shopping experience. Macy’s On Call app is tailored with answers for specific stores. Customers can chat with an AI-backed bot for inventory checking and directions to navigate around the store. Interestingly, the AI bot is able to detect if a customer is getting frustrated and alert a store associate for help.
These projects were already well in place before the pandemic but will play a bigger role post-COVID, serving as an example for other retailers seeking to incorporate technology. These AI-inspired solutions are customer-centric and could potentially take over the role of store associates, which helps reduce the risks for retail employees at this time.
IoT
If AI solutions are adopted for enhanced services and to ease the burden of store personnel, IoT is then famed for their data-driven approaches to turbocharge core operations in retail.
Recently, Auchan Retail Portugal, with a network of 34 supermarkets and hypermarkets across the European country, announced it would deploy a fleet of autonomous robots for optimized shelf monitoring.
These autonomous robots will circle around the stores up to three times daily to capture photos of every shelf and aisle. The captured photos are then digitized at scale with computer vision and IoT, and then converted into reports with actionable insights for store staff to act upon. The reports delivered through a mobile app will boost store employees’ efficiency in managing, prioritizing, and resolving shelf issues.Andre Vieira, Digital Director at Auchan Retail Portugal, noted that “innovation, through the search for digital strategies, focused on people and improving customer service is one of Auchan’s great bets. With the introduction of autonomous robots, Auchan wants to improve productivity in stores, and optimize the supply chain, freeing employees to focus 100% on the mission of providing a better customer experience.”
Posted by AGORACOM-JC
at 8:14 AM on Thursday, September 10th, 2020
Announced that it has entered into a sales agreement with 7-Eleven Korea for Robotic Process Automation infrastructure.
RPA is the technology that enables anyone to configure computer software today, or a “robot” to replicate and incorporate the actions of a person working within digital systems to conduct a business process
Global RPA market size is expected to reach $7.2 billion by 2025, rising at a market growth of 32.6% CAGR during the forecast period
Toronto, Ontario–(September 10, 2020) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex“) is pleased to announce that it has entered into a sales agreement with 7-Eleven Korea for Robotic Process Automation (“RPA”) infrastructure.
The global RPA market size is expected to reach $7.2 billion by 2025, rising at a market growth of 32.6% CAGR during the forecast period. RPA is the technology that enables anyone to configure computer software today, or a “robot” to replicate and incorporate the actions of a person working within digital systems to conduct a business process. An increased demand for business process automation (“BPA”) is expected to be the main growth driver through the use of Artificial Intelligence (“AI”) and RPA.[1]
7-Eleven is a international chain of convenience stores founded in 1927 in the United States with over 70,000 stores located around the globe. 7-Eleven has a legacy of innovation and delivering “what the customers want, when and where they want it.”
Datametrex is working closely with clients to power it through their digital initiatives and improve their delivery on innovation as they continue the pursuit of catering to a modern, digital-savvy generation of shoppers.
“At Datametrex, we continue our efforts to facilitate ground-breaking technologies to companies across the globe. Our technology is proven to be valuable to make sense of the data beyond complicated spreadsheets.” said Marshall Gunter, CEO of Datametrex. “We pride ourselves in providing tools that our clients can use to visualize their customer and stakeholder data. Through predictive analysis they can support their decision making, mitigate risk, and improve their bottom line.”
Investor Webinar
Datametrex also announces that senior management will be hosting an investor update webinar on Tuesday, September 15, 2020, at 1:00 p.m. ET to discuss the Company’s Second Quarter 2020 results, developments and contracts on the Artificial Intelligence technologies and COVID-19 test kits.
Datametrex plans to answer questions previously sent to [email protected]and during the webinar, at management’s discretion and subject to time constraints.
About Datametrex
Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.
For further information, please contact:
Marshall Gunter – CEO Phone: (514) 295-2300 Email: [email protected]
Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.____________________________________
Posted by AGORACOM-JC
at 6:56 AM on Thursday, September 10th, 2020
Commenced COVID-19 reverse transcription polymerase chain reaction (RT-PCR), testing through its Sun Valley Health operations in Arizona, using RT-PCR test kits and laboratory test processing by Kai Medical Laboratory in Dallas, TX., the recently announced proposed acquisition target by Empower
programs are part of a “Back to Work” and “Back to School” initiative supported by a variety of outbound marketing campaigns including new Facebook ads, text message & email campaigns and outbound call-center campaigns targeting businesses, universities & colleges, sports teams or organizations where effective social distancing could be difficult.
VANCOUVER BC / September 10, 2020 / EMPOWER CLINICS INC.(CSE:CBDT)(Frankfurt:8EC)(OTCQB:EPWCF) (“Empower” or the “Company“) today announces it has commenced COVID-19 reverse transcription polymerase chain reaction (RT-PCR), testing through its Sun Valley Health operations in Arizona, using RT-PCR test kits and laboratory test processing by Kai Medical Laboratory in Dallas, TX., the recently announced proposed acquisition target by Empower.
The programs are part of a “Back to Work” and “Back to School” initiative supported by a variety of outbound marketing campaigns including new Facebook ads, text message & email campaigns and outbound call-center campaigns targeting businesses, universities & colleges, sports teams or organizations where effective social distancing could be difficult.
Currently Kai Medical Laboratory has the capacity to complete in excess of 2,000 RT-PCR tests in one eight-hour shift by utilizing its Thermo Fisher QuantStudio 12k Flex testing machine.
“Launching our RT-PCR testing programs utilizing the capability of Kai Medical Labs gives us the ability to access massive testing volume not only in Arizona, but nationwide in the U.S.” said Steven McAuley, Empower’s Chairman & CEO. “Our team at Sun Valley Health has created numerous strategic marketing campaigns to drive awareness and testing volume, leveraging our supply chain improvements with increased profit margins.”
Many schools and universities are now requiring students and teachers to provide RT-PCR testing results prior to returning to campus. Our nasal or throat swab RT-PCR testing program allow students and teachers to quickly be tested and receive results from a Clinical Laboratory Improvement Amendments (CLIA), accredited laboratory in only 24 – 48 hours.
Businesses need a stable workforce, and must be quick to isolate employees with any symptoms. Our RT-PCR testing allows employees to be tested quickly and receive results within 24 – 48 hours, giving the employee and the employer the opportunity to activate non-contagious employees and safely return to work!
Travelers are also discovering demands to get a RT-PCR test and provide the result upon check-in at the airport. The reports are required to be no more than 3 days old. Our testing program provides accurate results within 24-48 hours, giving the patient a document that can make the difference in being able to travel.
An RT-PCR assay is a viral molecular test to detect active infection directly in a patient’s RNA genetic sequence. An RT-PCR swab test is considered the gold-standard for testing & diagnosing active viral infections and should be used for anyone who has symptoms or known exposure to COVID-19. These tests are renowned for high sensitivity and high specificity.
(CLIA) The Clinical Laboratory Improvement Amendments regulate laboratory testing and require clinical laboratories to be certified by the Center for Medicare and Medicaid Services (CMS) before they can accept human samples for diagnostic testing.
USA COVID-19 Data as at September 9, 2020 TOTAL CASES: 6,310,663 TOTAL DEATHS: 189,147 CASES IN LAST 7 DAYS: 262,971
ARIZONA as at September 9, 2020 CONFIRMED CASES: 204,239 PROBABLE CASES: 1,806 TOTAL CASES: 206,045 CASES IN LAST 7 DAYS: 3,703 CASES/100K: 2,873 DEATHS/100K: 72
TEXAS as at September 9, 2020 TOTAL CASES: 641,791 CASES IN LAST 7 DAYS: 24,458 CASES/100K: 2,236 DEATHS/100K: 47
ABOUT EMPOWER
Empower is a vertically integrated health & wellness company with a network of corporate and franchised health & wellness clinics in the U.S. The Company is focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The Company has launched Dosed Wellness Ltd. to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies, psilocybin and other psychedelic plant-based treatment options. The Company provides COVID-19 testing services to consumers and businesses as part of a four-phased nationwide testing initiative.
ABOUT Kai Medical Laboratory
Kai Medical Laboratory is a high-complexity CLIA and COLA accredited Laboratory that provides reliable and accurate testing solutions to hospitals, medical clinics, pharmacies, and employer groups. Kai Medical Laboratory offers a wide array of testing services ranging from hematology to hormone testing, endocrinology, toxicology, and immunology. These tests are done under the supervision of its well-qualified and highly experienced scientists, medical professionals, and pharmacists. https://www.kaimedicallaboratory.com
This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release.Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include, but are not limited to, statements regarding: the expected benefits to the Company and its shareholders as a result of the proposed acquisition of Sun Valley; the proposed transaction terms; the expected number of clinics and patients following the closing; the future potential success of Sun Valley’s franchise model; the anticipated date of closing of the acquisition and the occurrence thereof; and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including: that the Kai Medical Laboratory acquisition may not be completed on the terms expected or at all; that the Company’s products may not work as expected; that the Company may not be able to expand COVID-19 testing; that legislative changes may have an adverse affect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed transaction; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.
Posted by AGORACOM-JC
at 1:18 PM on Wednesday, September 9th, 2020
You’re invited to our Investor Webinar on September 15th @ 1 PM EST. We will be discussing the Q2 financials, and the following topics: COVID-19 Testing and AI technology.
Posted by AGORACOM-JC
at 10:45 AM on Thursday, September 3rd, 2020
Announced the largest purchase order to date from a Canadian Mining Company with operations worldwide
P.O. is for 50,000 1drop Inc.
P.O. is for their Peru and Surinam mining operations.
Total gross sales amount is approximately $1.6M CAD, excluding shipping and courier fees
COVID-19 test kits manufactured by 1drop Inc.
TORONTO, Sept. 03, 2020 — Datametrex AI Limited (the “Company” or “Datametrex“) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce the largest purchase order (the “P.O.”) to date from a Canadian Mining Company (the “Purchaser”) with operations worldwide. The P.O. is for 50,000 1drop Inc. This P.O. is for their Peru and Surinam mining operations. The total gross sales amount is approximately $1.6M CAD, excluding shipping and courier fees. The P.O. is for 50,000 COVID-19 test kits manufactured by 1drop Inc.
Under the terms of the P.O., Datametrex will provide the Purchaser with an initial 50,000 units of the COVID-19 qPCR Detection Kits manufactured by 1drop Inc. (“1drop”), 50,000 Universal Transport Medium (UTM®), Sterile Swabs with 16x100mm and Skirted Tubes. The Company is also shipping two (2) Real-Time Polymerase Chain Reaction Detection System (“PCR”) machines along with software to ensure optimal assay performance of the samples, and 50,000 RNA extraction kits.
Datametrex anticipates that it has little or no upfront costs associated with the sale of these test kits. All of the items are shipped directly from manufacturers to the purchaser’s mine operating sites in Peru and Surinam.
A publicly available survey provided by Statista with sources from Johns Hopkins University (CSSE), World Bank, and Insee, states that Peru is the most impacted country with the most deaths per million (908.8 deaths per million, at the date of this news release – source: https://bit.ly/3bikTRo). Also, Peru is the number two copper producer in the world and with the mining stoppages from the COVID-19 pandemic, combined with operational issues, mine output has declined by 23% over the first five months, with April and May registering declines of 33% and 41%, respectively, as stated by the International Copper Study Group recently reported – source: https://bit.ly/3i64Qc5
“Datametrex is glad to be able to help companies in Peru deal with this urgent situation. Assisting with the implementation of test kits is a fundamental response to the pandemic, and those mining companies that have been able to test more comprehensively have had greater success dealing with the pandemic,” says Marshall Gunter, CEO of the Company. “The reasoning is simple: An individual who tests positive can be isolated until they recover, and their contacts may be traced and similarly tested and isolated, effectively reducing the rate of transmission. We hope our technologies, combined with everyone’s efforts, contribute to the mitigation of the spread in operational mining sites.”
About Datametrex
Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational Health and Safety goals with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain.
Marshall Gunter – CEO Phone: (514) 295-2300 Email: [email protected]
Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.
Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.
Posted by AGORACOM-JC
at 8:18 AM on Tuesday, September 1st, 2020
Announced that the Company has submitted a Medical Devices Interim Order Request Form to approve PCL, Inc.’s COV05 COVID19 Rapid Antigen Detection Kits to Health Canada
Application is made under IO Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19 pursuant to subsection 30.1(1) of the Food and Drugs Act signed by the Minister of Health on August 24, 2020, for PCLCOV05 COVID19 Rapid Antigen Detection Kits.
TORONTO, Sept. 01, 2020 – Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC:DTMXF ) is pleased to announce that the Company has submitted a Medical Devices Interim Order (“IO”) Request Form to approve PCL, Inc.’s (“PCL”) COV05 COVID19 Rapid Antigen Detection Kits to Health Canada.
This application is made under IO Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19 pursuant to subsection 30.1(1) of the Food and Drugs Act signed by the Minister of Health on August 24, 2020, for PCLCOV05 COVID19 Rapid Antigen Detection Kits. This IO will allow Health Canada to issue expedited review and approval for the sale of these test kits in Canada.
The Company has represented to Health Canada that it will be able to provide a minimum first order of 200,000, followed by an additional 200,000 units on a weekly basis. Any purchase of the test kits by the Canadian government is conditional on prior receipt of Health Canada approval.
These test kits are suitable for point of care tests. No extra equipment is needed. They are simple to use and results are available in 10 minutes.
“According to the manufacturer, PCL, this test can detect antigens of COVID-19 from a swab in the nose and throat to provide results in 5-10 minutes with over 86% accuracy,” said Marshall Gunter, CEO of Datametrex. “These almost-instant kits can be easily used at home. With the rise of cases in the United States and throughout the world, we at Datametrex believe it is critical to test and protect.”
According to PCL the clinical sensitivity (confirmed the actual positive of the approved person where approved person tested positive with a PCR nucleic test) is 86.49% and the clinical specificity (confirmed the actual negative of the negative person where the negative person tested negative with a PCR nucleic test) is 97.87%*. Early detection using rapid tests will also provide further protection to Canada’s front-line workers, especially health care professionals.
The following certifications have been awarded to these PCL Antigen Test Kits: CE Certificate, Korea KPMG, FIND Listed, UNGM Supplier. Countries includes the EU, 2 countries in the Middle East- Qatar and UAE, India, Russia, 3 countries in Latin America- Guatemala, Ecuador, and Colombia.
The PCL Inc Antigen Detection kit has the CE Certificate meaning that the manufacturer and products have met EU declaration of standards for health, safety, and environmental protection, allowing this product to be sold within the 22 countries in the European Economic Area.
Health Canada must approve these COVID-19 test kits before they can be used in Canada. The Company plans to sell these kits in all countries where the kits have been approved for sale. Datametrex anticipates that it will have little or no upfront costs associated with importing these test kits. Assuming Health Canada approves the test kits and they are subsequently purchased by the Canadian government, manufacturer will ship the test kits directly to the Canadian government or hospitals, and Datametrex will not be involved in the shipping, warehousing or distribution process.
* Clinical Accuracy
The clinical performance of the PCL COVID-19 Ag Rapid FIA was evaluated in two different institutions compared to RT-PCR positive cases. Positive percent is 86.49% (95% CI: 70.43-94.92%) and negative percent agreement is 97.87% (95% CI: 87.28%-99.89%) in the PCL COVID-19 Ag Ripid FIA.
COVID-19 Ag Ripid FIA.
RT – PCR
PPA (%)
NPA (%)
POS
NEG
Site 1
POS
20
0
100.00
96.00
NEG
0
20
Total
20
20
Site 2
POS
12
1
70.59
100.00
NEG
5
26
Total
17
27
Total
POS
32
1
86.49
97.87
NEG
5
46
Total
37
47
About Datametrex
Datametrex AI Limited is a technology-focused with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.
For further information, please contact: Marshall Gunter – CEO Phone: (514) 295-2300 Email: [email protected]
Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not historical may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.
Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the time such forward-looking information is made. Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.
